ABT-737-induced apoptosis. Indeed, ABT-737 and its analog ABT-263 show reduced
ABT-737-induced apoptosis. Indeed, ABT-737 and its analog ABT-263 show lowered efficacy against nodally primarily based CLL cells compared with circulating disease.51,52 This might clarify the divergent efficacy of ABT-737 against…